Literature DB >> 6303639

Blood pressure and metabolic effects of ACTH in normotensive and hypertensive man.

J A Whitworth, D Saines, R Thatcher, A Butkus, B A Scoggins.   

Abstract

ACTH administration (0.5 mg Synacthen Depot I/M 12 hourly for 5 days) significantly increased systolic blood pressure in normotensive subjects (n=6) and mild essential hypertensives (n=6) but not in 2 Addisonian women, indicating that the pressure rise was adrenally dependent. ACTH administration was associated with urinary sodium retention, hypokalaemia, elevation of fasting blood glucose, lymphopaenia and eosinopaenia. Body weight was increased only in the normotensive subjects. Plasma renin concentration fell and renin substrate rose. Inactive renin fell in the hypertensive subjects only. Plasma cortisol, 11-deoxycortisol, corticosterone, deoxycorticosterone, 17 alpha-hydroxyprogesterone and 17-hydroxy, 20-dihydroprogesterone were all increased by ACTH treatment. Plasma aldosterone rose initially in the normotensives but then fell. ACTH administration in man produces metabolic and hormonal changes similar to those produced by ACTH in sheep but the rise in blood pressure is systolic only in man. The steroid(s) responsible for the blood pressure rise with ACTH in man have not been defined.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6303639     DOI: 10.3109/10641968309081788

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  3 in total

1.  Biobehavioral effects of extended salt loading and conflict stress in intact baboons.

Authors:  J S Turkkan
Journal:  J Exp Anal Behav       Date:  1994-03       Impact factor: 2.468

Review 2.  Cardiovascular consequences of cortisol excess.

Authors:  Judith A Whitworth; Paula M Williamson; George Mangos; John J Kelly
Journal:  Vasc Health Risk Manag       Date:  2005

3.  Comparison of Bolus and Continuous Infusion of Adrenocorticotropic Hormone During Adrenal Vein Sampling.

Authors:  Jinbo Hu; Jiangqiong Chen; Qingfeng Cheng; Ying Jing; Jun Yang; Zhipeng Du; Ying Song; Linqiang Ma; Yi Yang; Ting Luo; Yue Wang; Qifu Li; Shumin Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-26       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.